| Year |
Citation |
Score |
| 2020 |
Garbern JC, Escalante GO, Lee RT. Pluripotent stem cell-derived cardiomyocytes for treatment of cardiomyopathic damage: Current concepts and future directions. Trends in Cardiovascular Medicine. PMID 31983535 DOI: 10.1016/J.Tcm.2020.01.002 |
0.312 |
|
| 2019 |
Garbern JC, Helman A, Sereda R, Sarikhani M, Ahmed A, Escalante GO, Ogurlu R, Kim SL, Zimmerman JF, Cho A, MacQueen L, Bezzerides VJ, Parker KK, Melton DA, Lee RT. Inhibition of mTOR Signaling Enhances Maturation of Cardiomyocytes Derived from Human Induced Pluripotent Stem Cells via p53-Induced Quiescence. Circulation. PMID 31707831 DOI: 10.1161/Circulationaha.119.044205 |
0.317 |
|
| 2019 |
Goldstein JM, Sengul H, Messemer KA, Fernández-Alfara M, Garbern JC, Kristl AC, Lee RT, Wagers AJ. Steady-state and regenerative hematopoiesis occur normally in mice in the absence of GDF11. Blood. PMID 31530563 DOI: 10.1182/Blood.2019002066 |
0.312 |
|
| 2019 |
Hajipour MJ, Mehrani M, Abbasi SH, Amin A, Kassaian SE, Garbern JC, Caracciolo G, Zanganeh S, Chitsazan M, Aghaverdi H, Kamali Shahri SM, Ashkarran A, Raoufi M, Bauser-Heaton H, Zhang J, et al. Nanoscale Technologies for Prevention and Treatment of Heart Failure: Challenges and Opportunities. Chemical Reviews. PMID 31490059 DOI: 10.1021/Acs.Chemrev.8B00323 |
0.327 |
|
| 2017 |
Garbern JC, Daly KP. Into the hearts of babes: Stem cell therapy for pediatric heart failure. The Journal of Heart and Lung Transplantation : the Official Publication of the International Society For Heart Transplantation. PMID 28365176 DOI: 10.1016/J.Healun.2017.03.006 |
0.333 |
|
| 2013 |
Garbern JC, Lee RT. Cardiac stem cell therapy and the promise of heart regeneration. Cell Stem Cell. 12: 689-98. PMID 23746978 DOI: 10.1016/J.Stem.2013.05.008 |
0.366 |
|
| 2013 |
Garbern JC, Mummery CL, Lee RT. Model systems for cardiovascular regenerative biology. Cold Spring Harbor Perspectives in Medicine. 3: a014019. PMID 23545574 DOI: 10.1101/Cshperspect.A014019 |
0.319 |
|
| 2011 |
Garbern JC, Minami E, Stayton PS, Murry CE. Delivery of basic fibroblast growth factor with a pH-responsive, injectable hydrogel to improve angiogenesis in infarcted myocardium. Biomaterials. 32: 2407-16. PMID 21186056 DOI: 10.1016/J.Biomaterials.2010.11.075 |
0.4 |
|
| 2010 |
Garbern JC, Hoffman AS, Stayton PS. Injectable pH- and temperature-responsive poly(N-isopropylacrylamide-co-propylacrylic acid) copolymers for delivery of angiogenic growth factors. Biomacromolecules. 11: 1833-9. PMID 20509687 DOI: 10.1021/Bm100318Z |
0.462 |
|
| 2007 |
Garbern JC, Hoffman AS, Stayton PS. DEVELOPMENT OF AN INJECTABLE PH- AND TEMPERATURE-RESPONSIVE HYDROGEL DRUG DELIVERY SYSTEM. Journal of Investigative Medicine. 55: S113. DOI: 10.1097/00042871-200701010-00235 |
0.465 |
|
| 2004 |
Smith MK, Peters MC, Richardson TP, Garbern JC, Mooney DJ. Locally enhanced angiogenesis promotes transplanted cell survival. Tissue Engineering. 10: 63-71. PMID 15009931 DOI: 10.1089/107632704322791709 |
0.319 |
|
| Show low-probability matches. |